Premier Perspectives The blog for insider insights in clinical development Medical and Regulatory Affairs Bringing Drugs for Depression to Market: US and EU Regulatory Frameworks By Adam Simmons June 19, 2024 Featured Posts Clinical ResearchPhase 1 - Phase 4 Navigating the FDA’s Draft Guidance on Psychedelic Drug Development By Adam Simmons October 18, 2023 Clinical ResearchPhase 1 - Phase 4 Leveraging Technology and Expert Clinician Review to Enhance Risk Detection in Neuroscience Studies By Adam Simmons October 16, 2023 1 × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today
